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Introduction
The environmental factors are considered to
have a very important role in the development of
different types of carcinoma (1,2). Among them, the
nutritive factors containing initiators and promoters of
carcinogenesis or acting as genotoxic carcinogens are
of special importance. On the other hand, some
nutritive deficiencies may influence the appearance of
malignant diseases (3,4). Therefore, Marshal et al.
showed that the risk of oral carcinoma development
increased along with the decrease of vitamin A and
vitamin C (ascorbic acid) intake (5). These facts are
supported by the results of Graham et al. claiming that
vitamin C had a preventive role in the development of
laryngeal carcinoma (6). Several epidemiological
studies showed that the consumption of vitamin C
within the food intake decreased the risk of
gastrointestinalandothermalignanttumorsappearance
(7,8). The study of Cameron and Pauling showed the
beneficial effect of the application of high dosage of
vitamin C on the patients’ survival in the terminal stage
of malignant disease (9). However, these results were
not confirmed by Cregan et al. (10).
The results of several experimental studies
concerning the relationship between vitamin C and
malignant tumors have been published. Pauling et al.
showed that spontaneous appearance of mammary
carcinoma in mice corresponded with the decrease of
ascorbic acid concentration in serum (11). Fraizer and
McGinn published data claiming that the addition of
vitamin C (1mg/ml) in drinking water led to the
significant increase of the survival time of C3H/HEJ
mice after the implantation of mammary
adenocarcinoma cells (12). However, Abul-Haij and
Kelliher did not obtain the same results by applying a
similar experimental model (13).
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TIn our previous study we demonstrated that high doses of ascorbic acid prolonged the
survival of mice with experimental mammary carcinoma. In this work we studied, ussing the
same model, pathohistological characteristics of the tumor and phenotypic changes of lympho-
cyte subsets in the spleen. Experiments were performed on CBA/H mice. The growh of experi-
mental tumor was induced by injection of mammary adenocarcinoma cells intramuscularly at
the femoral region of mice. The animals were divided into control group and three experimental
groups(I,IIandIII).Micefromexperimentalgroupsweretreatedperoralywith10mg/,100mg
/ and 1000 mg / kg body mass (b.m.) of ascorbic acid, respectively, whereas control mice re-
ceived physiological saline. Mice were sacrified after 7, 14 and 21 days from the beginning of
the experiment. Total tumor mass and its pathohistological characteristics, spleen mass and
cellularity as well as relative and total numbers of T cells, B cells and T cell subsets (CD4+ and
CD8+) in the spleen, were analyzed. High doses of ascorbic acid decreased tumor mass, stimu-
lated proliferation of fibroblasts and formation of capsula arround the tumor, induced tumor ne-
crosis and increased the number of tumor infiltrating lymphocytes. Changes of lymphocyte
subsets and their numbers varied depending on the applied dose of ascorbic acid and the time
elapsed following tumor induction. The most prominent changes, manifested by an increase in
thenumberofCD4+Tcellswereobserved onthe14thdayinIIexperimentalgroup. Ourresults
suggest that the beneficial effect of ascorbic acid on experimental tumorogenesis in our model
was the consequence of its influence on the tumor and on the immune system. Acta Medica
Medianae 2005; 44(2): 23‡31.
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www.medfak.ni.ac.yu/ammOur previous research using a model of experi-
mental mammary adenocarcinoma in CBA/H mice
showed that vitamin C (1000mg/body mass) prolonged
the survival period of these animals in comparison to
the control (14). In this work, we wanted to examine
histopathologicalcharacteristicsoftumorandsomeim-
munological parameters on the same model. This
would in turn enable better perception of the possible
mechanismsofthevitaminCeffectonthedevelopment
of experimental mammary carcinoma.
Materials and methods
Experimental animals
The experiments were carried out with female
CBA/H mice, between 7 and 8 weeks of age, weighing
20 to 24 g. Until the onset of the experiment, the
animals had lived under usual laboratorial conditions.
They were fed with paletted food, while the water was
givenfromfeedingcupadlibitum.VitaminsofBgroup
wereaddedtothedrinkingwater.60micewereusedfor
the experiment.
Experimental tumor induction
Tumor induction in experimental animals was
carried out by injecting 5x106 mouse mammary
adenocarcinoma living cells in femoral musculature.
After that, the animals were randomly divided into one
control and three experimental groups (I,II,III). The
mice of the experimental groups were given ascorbic
acid solution through gastric sonde in the overall vol-
ume of 0,5 ml during the period of 5 days in a single
week. Experimental group I was given 10 mg of ascor-
bic acid/kg of body mass (b.m), experimental group II
was given 100 mg/kg b.m., whereas experimental
group III received 1000 mg/kg b.m. Ascorbic acid was
dissolved in physiological solution. The mice of the
control group were given the same volume of physio-
logical solution.
The animals were sacrificed by ether anesthesia
on the 7th,14th and 21st day after tumor induction. There
were 10 animals in each group. After the tumor and
spleen extraction, their mass was weighed. The tumor
tissue was further treated for pathohystological analy-
sis, whereas the spleen was used for immunological ex-
aminations.
Pathohystological analysis
Severalcut-outpartsweretakenfromeachtumor
andfixedin10%bufferedformalin;afterdehydratation
in alcohol and enlightening in xylol, they were embed-
ded in paraffin. Paraffin blocks were cut on microtome
(Richert-Jung) into 5-7 micrometers thick slices and
mountedontomicroscopicslides.Afterdeparaffinizing
process, the slides were stained according to Azan and
Van-Gieson method. The pathohystological analysis
was carried out by light microscopy. The results were
descriptively presented and illustrated by the photo-
graphs.
Cytofluorimetric analysis
The spleen was macerated through the iron mesh
soaked into Petryv’s dishes with the solution of
phosphatebufferedsaline(PBS)bypressingtheplugof
asyringe.Thus,weobtainedcellsuspensionwhichwas
afterwards rinsed by centrifugation. The counting of
cells was done in the standard manner using Turck’s
solution. Erythrocytes from the cells of the spleen were
lysed with ammonium sulfate. After being counted
once again, splenocytes were divided into test tubes for
fluorescence, in concentration of 1x106 cells per each
test tube in the volume of 100 L. Antibodies
conjugated with fluorescein isotocianate (FITC) were
added to cells. The following antibodies reactive with
the mouse antigens were used: Thy1.2 (pan T cell
marker); membrane immunoglobulin (Ig)
(B-lymphocyte marker); CD4 and CD8. Antibodies
were commercially obtained from Serotec, while CD4
was from Beckton-Dickinson. Antibodies were diluted
in PBS with the addition of 2% of fetal calf serum, and
0,1% Na-azide, in concentration of 2,5 g/ml. The
control consisted of cell samples incubated without
antibodies. After the 45-minute incubation at +4oC the
cells were washed in PBS and then fixed in 1%
formalin and analyzed by flow cytometryeter
(EPICS-CS, Coulter). The population of lymphocytes
wasidentifiedonthebasisofforwardscaterversusside
scatercharacteristics.Thelevelofspecificfluorescence
was determined on the basis of fluorescence profile in
control samples that did not exceed 2%. The results
were shown as percentages of positive cells for each
marker. The total number of lymphocyte
subpopulations was counted according to the relative
values and the total number of lymphocytes.
Statistical Analysis
For the statistical data management, the
Student’s t test for small samples was used. Statistical
significance between the examined groups was defined
at the p<0,05 level.
Results
The effect of ascorbic acid on mass and
histopathological characteristics of tumor during the
development of experimental mammary carcinoma.
The first part of the results in this paper referred
to the examination of growth dynamic and
histopathological characteristics of tumor during the
induction of experimental mammary carcinoma.
Table1showsthattumorgrowthinexperimental
groups of mice, measured by its total mass, was slower
in relation to the control group. However, statistically
significant difference in tumor mass was noticed only
on the 21th day between III experimental group (mice
treated with ascorbic acid in dose of 1000 mg/kg b.m.)
and the control group.
The results of pathohistological analysis of ma-
mmary carcinoma in control animals show that tumor
tissues were predominately composed of malignant
cells with high mitotic index, hyper-chromatic nuclei
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favor of the nuclei. Tumor growth was followed by
infiltration of surrounding musculature with gradual
atrophy of muscle cells. Since the reactivity of
connectivetissueislacking,thecapsulewasnotformed
even in the end of the examined period. Rare lymphoid
cells were present in tumor. Hemorrhagic areas were
noticed at some places (Figure 1).
In mice treated with ascorbic acid, a slower infi-
ltrative tumor growth inside the muscles was noticed.
This process is more likely to be noticed in animals
treated with vitamin C in dosages of 100 mg/kg t.m. and
1000 mg/kg b.m. Also, there is the presence of a strong
lymphoplasmatic infiltration which is in direct
correlation with the applied dosage of vitamin C.
Proliferation of fibroblasts can be noticed inside the
tumor, as well as in the capsule around it. The capsule
was very discrete in I experimental group and developed
and prominent in the III experimental group. Hemo-
rrhagic and necrotic zones inside the tumor at the end of
examinedperiodweresignificantlynoticeableincompa-
rison to the control group. Necrosis was particularly
characteristic for tumors in animals of the III expe-
rimental group in which proliferated collagen in tracts
separatenecroticareasofcarcinogenictissue(Figure2).
In mice treated with ascorbic acid (10 mg), a
deceleration of infiltrative tumor growth progression
inside the muscles was observed; there were a
proliferation of connective tissue, a discrete formation
of capsula infiltrate by lymphocytes in the first part of
the experiment (Figure 3).
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Table 1. The effect of various doses of ascorbic acid on the dynamic of tumor mass changes in mice during the development
of experimental mammary carcinoma
Animal group Tumor mass (g)
7. day 14. day 21 day
Control 0.51 ± 0.01 4.25 ± 0.90 9.79 ± 1.03
Experim. I 0.43 ± 0.03 4.09 ± 0.87 8.87 ± 0.88
Experim. II 0.48 ± 0.04 2.97 ± 0.05 9.12 ± 0.99
Experim. III 0.43 ± 0.05 2.93 ± 0.07 8.37 ± 0.86*
Mean values were shown ±SD for 10 animals in each group
*=p<0.05 in comparison to the control.
Figure 1. Strong tumor proliferation holds back the bundles
of skeletal muscles and leads to their atrophy as well
Figure 2. Compact, highly proliferative tumor mass sur-
rounded by the area of hemorrhage and edematization
of connective tissue
Figure 3. Wide tumor tissue zone with hardly perceivable
capsula infiltrated by lymphocytesIn mice treated with 100 mg of ascorbic acid, on
the pathohistological preparation obtained during the
assay, some changes in tumor mass in the form of
haemorrhagia, necrobiosis and necrosis were noticed.
However, in the end of the assay, we noticed
necrobiosis of cancer cells, their discomplexion and
lymphocytic infiltration with both well-developed and
wide girdle of fibro collagen capsula (Figure 4).
In mice treated with 1000 mg of ascorbic acid,
during the first week of the assay, a lymphocytic
infiltrationoccursalongwithfibroblasticreaction,both
inside the tumor and skeletal muscles (Figure 5).
At the end of the experiment, in animals of
experimental group, there is subcapsular direction, that
is, towards the tumor. Moreover, there were areas of
progressive proliferation of fibroblast, the appearance
of collagen in the capsular part (Figure 6) as well as its
condensation (Figure 7).
The influence of ascorbic acid on mass and
spleen cellularity in mice during the development of
experimental mammary carcinoma. Ourfurtherresearchcheckedthekindofchanges
taking place in spleen of animals during the
development of experimental mammary carcinoma.
We chose spleen having in mind that it comprises the
largestperipherallymphoidorganinmice,andwhichis
in turn the most significant source of lymphocytes for
both ex vivo and in vitro research.
The results presented in Table 2 show that in the
control group of animals, the tumor growth was
followed by the increase in mass and spleen cellularity.
In the experimental group of mice, the increase of
cellularity and mass of spleen was less in relation to the
control group. At the end of the examined period
(21thday) the greatest decrease of spleen cellularity
(around 35%), in relation to the control group, was
noticed in animals of the III experimental group.
The influence of ascorbic acid on phenotype
characteristics of spleen lymphocytes in mice during
thedevelopmentofexperimentalmammarycarcinoma.
The results of research of relative and total
valuesofTandBlymphocytenumbersaswellasCD4+
and CD8+ T subpopulations of spleen lymphocytes of
26
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Figure 4. Subcapsular lymphocytic infiltration of a tumor
capsula part which is well-developed and rich in both
fibroblasts and collagen fibers
Figure 5. Tumor mass seizes and stratifies skeletal muscle,
shows the signs of necrobiosis, fibroblasts proliferation and
lymphocytic infiltration
Figure 6. Above the hemorrhagic- necrotic area, there is a
relatively vital tumor tissue; above the tissue, there is a wide
fibroblast capsula with the domination of collagen fibers
bundles
Figure 7. Strong connective tissue interposes between the
tumor and muscular tissuemice during the development of mammary carcinoma
were presented in Tables 3 and 4. In mice belonging to
the control group, the percentage of T lymphocytes
(Thy 1.2+ cells) was progressively becoming lower
during the examined period of time. However, due to
the increased spleen cellularity, their absolute number
was not significantly changed. The relative values of B
lymphocytes increased in the period of 7 -14 days and
then decreased from the 14th ‡2 1 st day. Similar
dynamics of change was noticed in the overall number
ofBlymphocytes.RelativevaluesofCD4+andCD8+T
lymphocytes were decreased from 7-14-day period,
while absolute values gradually increased during the
examined period. (Table 3,4).
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Table 2. The effect of various dose of ascorbic acid on the dynamic of mass and spleen cellularity changes in mice during
the development experimental mammary carcinoma
Animal group Spleen mass (mg) (A)
Cellularity(x1 0 7) (B)
7. day 14. day 21. day
Control A
B
1 4 8±1 0
8.4 ± 0.7
3 4 2±5 7
14.0 ± 1.4
4 8 8±7 0
26.4 ± 4.5
Experim. I A
B
1 3 8±1 5
8.7 ± 1.0
2 9 6±3 8
11.6 ± 2.1*
408 ± 12*
22.5 ± 5.6
Experim. II A
B
122 ± 12**
7.6 ± 0.2*
248 ± 43*
12.9 ± 1.7
4 3 6±8 5
22.3 ± 4.3
Experim. III A
B
110 ± 21**
7.0 ± 0.2*
262 ± 49**
11.5 ± 1.6*
384 ± 63*
17.7 ± 3.8*
Mean values were shown ±SD for 10 animals in each group
*=p<0.05; **= p<0.01 in relation to the corresponding control group
Table 3. The effect of various doses of ascorbic acid on the dynamic of relative value changes of lymphocyte subpopulation
in spleen of mice during the development of experimental mammary carcinoma
Animal
group subpopulations Lymphocyte
%
7. day 14. day 21 day
Control Thy 1.2 29.8±4.1 18.7±3.2 14.9±2.1
B Ly 51.4±6.6 61.6±2.2 41.8±3.6
CD4+ 20.3±3.2 12.5±2.4 15.5±3.2
CD8+ 5.8±0.8 3.7±0.9 3.6±0.5
Experim. I Thy 1.2 26.6±2.4 23.4±2.6* 15.3±2.7
B Ly 54.4±3.2 63.7±6.9 44.8±6.8
CD4+ 20.2±1.2 16.6±2.3* 13.2±1.9
CD8+ 5.6±0.5 4.9±0.4* 4.1±0.8
Experim. II Thy 1.2 27.5±2.2 23.1±1.5* 15.1±1.8
B Ly 51.6±2.9 64.1±1.9 48.8±9.5
CD4+ 19.6±1.6 16.8±1.7* 17.4±3.3
CD8+ 5.7±0.9 4.7±0.3* 3.9±0.6
Experim. III Thy 1.2 24.4±2.7 18.1±2.6 16.4±1.1
B Ly 56.2±3.8 64.1±3.0 49.2±6.0*
CD4+ 19.4±1.6 15.8±1.2* 18.6±2.3
CD8+ 5.5±1.1 4.0±0.9 4.6±1.2
Mean values were shown ±SD for 5 animals in each group
*=p<0.05 in relation to the corresponding control groupInmicetreatedwithascorbicacid(groupIandII)
statistically more significant relative values of T ly-
mphocytes were found on the 14th day compared to the
control group. However, the values of the total number
of T lymphocytes did not significantly change, except
on the seventh day when fewer numbers of T lympho-
cytes were recorded in the III experimental group.
When relative values of B lymphocytes were
analyzed, it could be noticed that a statistically
significant increase of these cells occurred only in III
experimental group, on the 21st day (p < 0,05) in
relation to the control group. No significant differences
were found in the total number of B lymphocytes
during the whole examined period between the
experimental groups and the control group of mice.
Relative CD4+T values of lymphocytes in
animals of all experimental groups were statistically
higher on the 14th day in relation to the control group,
whereas the relative values of CD8+T lymphocytes,
duringthesame examinedperiod,inanimalsofIandII
experimental groups were higher in comparison with
the mice of the control group. The absolute values of
CD4+T lymphocytes in animals belonging to II
experimentalgroupwerestatisticallyhigheronthe 14th
day when compared to the control one, while absolute
values of CD8+T lymphocytes in animals of III
experimental group were statistically lower on the 7th
day from tumor induction, in relation to the control.
Discussion
This experimental work was initiated by the
up-to-date knowledge about the importance of vitamin
C for numerous physiological processes in organism
including immunological, metabolic and anti-oxidative
processes, as well as its lower concentration in patients
with malignant diseases, and the controversial literary
data concerning anti-tumor effect of high doses of
vitamin C (9,10,12,13,15,16,17,18). According to our
previous results, ascorbic acid prolongs the survival of
mice with experimental mammary adenocarcinoma
(14). In this paper, we wished to examine, using the
same model, histopathological characteristics of tumor
and some of immunological parameters for better
understanding of the previously defined phenomenon.
Our results showed that vitamin C in a do-
se-dependant manner decreased the tumor mass, and
that the highest dose (1000 mg/kg b.m.) had the highest
effect. The decrease of the tumor mass may be the con-
sequence of the direct effect of vitamin C on the prolif-
eration of malignant cells or, its indirect effect on the
stimulationoffibroblastproliferationandtumorencap-
sulation. Even though direct inhibitory effect of high
dose of vitamin C on malignant cells proliferation was
shown in some in vitro examinations, more detailed
mechanisms have not been studied further (4,19). Tu-
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Table 4. The effect of various doses of ascorbic acid on the dynamic of absolute values change of lymphocyte subpopulation
in spleen of mice during the development experimental mammary carcinoma
Animal
group subpopulations Lymphocyte
(x1 0 6)
7. day 14. day 21 day
Control Thy 1.2 1.6±0.2 1.7±0.2 1.9±0.5
B Ly 2.8±0.4 5.6±0.4 5.3±0.7
CD4+ 1.1±0.1 1.1±0.2 2.0±0.6
CD8+ 0.3±0.1 0.3±0.1 0.4±1
Experim. I Thy 1.2 1.4±0.1 1.8±0.3 1.7±0.5
B Ly 2.9±0.5 4.9±1.1 4.9±1.0
CD4+ 1.1±0.1 1.2±0.2 1.5±0.5
CD8+ 0.3±0.1 0.4±0.1 0.5±0.1
Experim. II Thy 1.2 1.3±0.2 2.0±0.3 1.6±0.2
B Ly 2.5±0.1 5.6±0.8 5.0±1.0
CD4+ 0.9±0.1 1.5±0.2* 1.8±0.3
CD8+ 0.3±0.1 0.4±0.1 0.4±0.1
Experim. III Thy 1.2 1.1±0.2** 1.4±0.3 1.4±0.3
B Ly 2.7±0.6 4.9±0.9 4.1±1.0
CD4+ 0.9±0.2 1.1±0.2 1.6±0.5
CD8+ 0.2±0.01* 0.3±0.1 0.4±0.1
Mean values were shown ±SD for 10 animals in each group
*=p<0.05; **= p<0.01 in relation to the corresponding control groupmor cells release an enzyme hyaluronidase, which
breaks the hyaluronic acid in intracellular matrix of the
surrounding tissues, thus weakening these tissues and
permitting their infiltration by malignant cells. It
changes physio-chemical features of the tissue includ-
ing viscosity and adhesiveness. Thus, proliferation is
alleviated, as well as metastasis of malignant cells.
Ascorbic acid is necessary for synthesis of one
glycoprotein called physiological hyaluronidase inhib-
itor (PHI). It blocks the depolymerization process of
glycosaminoglycan and depolymerization of matrix
(20,21,22). During the tumor growth, due to the in-
creaseutilizationofascorbate,thereservoirsofvitamin
C are wasted, particularly in the central zones of the tu-
mor (23). Therefore, the concentration of PHI is re-
duced,whichinturnsprovidesnecessaryconditionsfor
thefastergrowthofmalignantcells.Therefore,itislog-
ical to consider that application of vitamin C will have
protective effect by the activation of the synthesis of
PHI.
The change in histopathological structures of
mammaryadenocarcinomawhichwaspresentedinthis
paper can also be explained by the effect of vitamin C
on collagen synthesis. Namely, the precursor of colla-
gen(pro-collagen)whichissynthesizedinfibroblastsis
rich both in proline and in lysine. Ascorbic acid which
enables hydroxylation of proline and lysine into
hydroxyl-proline and hydroxyl-lysine is necessary for
the conversion of pro-collagen into collagen. Thus,
maturation of collagen is stimulated as well as further
formationofcollagenfibers,whicharepartsofconnec-
tive tissue (22,24,25). Besides hampering its growth,
tumor encapsulation blocks the transportation of nutri-
tive substances into the tumor tissue. This is the reason
for the appearance of necrosis and hemorrhage which
were present in tumors of animals treated with the high
dose of vitamin C in our study.
Malignant tumors stimulate immunological
system of a host (26). This is also confirmed by our
results based on the following phenotypic features and
the number of lymphocytes in the spleen of the control
animals. At the beginning, the growth in the number of
B lymphocytes was greater in relation to the growth in
the number of T lymphocytes. Later (during the second
and the third week), relative values of all
subpopulations of lymphocytes were decreasing,
whereas their absolute values did not increase despite
the expectation, having in mind a progressive increase
of the total spleen cellularity. That may be the
consequence of inhibitory effect of already developed
tumor on the immune system. Numerous clinical or
experimental studies, which have been conducted so
far, showed that tumor had immunosuppressive effects
on activation, proliferation, and effector functions of
both specific and nonspecific immunity components
(26,27,28). One of the immunosuppressive mecha-
nismscouldbeexplainedasthedeficiencyofvitaminC
during the period of tumor growing, considering its
already proven effect on immune system (4,15).
In animals treated with vitamin C, various
changes were noticed in phenotype features and in the
number of lymphocytes in spleen. They depended on
the dose of vitamin C as well as the examined period.
Even if the changes were noticed in animals having
been given the smallest dose of vitamin C, they were
morevisibleinIIandIIIexperimentalgroup.Generally
speaking, it can be said that in the first part of examina-
tion (up to the period of two weeks) the number of T
lymphocytes statistically increased compared to the
control, mostly on the number of CD4
+T cell subset.
This increase was the most obvious in II experimental
group.Itiswell-knownthatCD4
+Tlymphocytesarethe
most significant cells for the onset of T cell immune re-
sponse, activation of specific cytotoxicity mediated by
NK cells, macrophage activation, as well as for activa-
tion and regulation of humoral immunity to protein an-
tigens (29). All these components of the immune
system are involved in antitumor immunity. In some
otherexperimentaltumormodelsithasbeenshownthat
the ascorbic acid treatment brought to the increase in
the number of CD4
+T lymphocytes (30,31). Vitamin C
exerts also the stimulating effect on the proliferation of
lymphocytes in culture in the presence of mitogens
(20,21,30,32,33), and the phenomenon is in correlation
with the increase in vitamin C concentration in acti-
vated lymphocytes (20,21,30,32,33,). Since ascorbic
acid is important for lymphocytes proliferation, lower
concentrations of this vitamin during the period of ad-
vanced tumor growth may be also significant for the
suppression of immunological reactivity.
One paradoxical finding in this paper is the de-
crease of spleen cellularity as well as further limitation
in the increase of the number of lymphocytes in the
third week of the experiment carried out on animals
treated by vitamin C, although the opposite results
would be expected. These results may be explained by
the fact that despite vitamin C application along with
the advance of tumor growth, its immunosuppressive
effects surpass beneficial effects of vitamin C. How-
ever, they can be explained by the increased migration
of lymphocytes from spleen into the tumor tissue,
which is in accordance with our histopathological find-
ings. Namely, we showed that with progressive tumor
growth and the increase in vitamin C dosage, the num-
ber of tumor lymphocytes increased as well. Tumor in-
filtrating lymphocytes whose T cell receptors are
specific for tumor antigens, possess antitumor effects
both in vitro and in vivo (26,34). Up to now, there have
been no experimental confirmations whether vitamin C
has a direct or indirect effect on the migration of tumor
infiltrating lymphocytes, whether therapeutic doses of
vitamin C lead to their activation in vivo, and whether
these cells are involved in the process of tumor necro-
sis. Therefore, our preliminary results are a good start-
ingpoint-basisforfurthermorecomplexexaminations
of this rather intriguing phenomenon.
According to our results, it can be concluded that
vitaminCmodulatesbothgrowthandhistopathological
characteristics of experimental mammary carcinoma in
micebystimulatingthesynthesisofcollagen,prolifera-
tion of connective tissue and tumor encapsulation, in-
creasing infiltration of lymphocytes in the tumor tissue
and activating the immune system.
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UTICAJ ASKORBINSKE KISELINE NA
PATOHISTOLO[KE KARAKTERISTIKE TUMORA I
FENOTIPSKE KARAKTERISTIKE LIMFOCITA
ZA VREME RAZVOJA EKSPERIMENTALNOG
MAMARNOG KARCINOMA U MI[EVA
Zorica Pavlovi} i Voja Pavlovi}
U prethodnoj studiji prikazali smo da visoke doze askorbinske kiseline prolongiraju
pre`ivljavanje mi{eva sa eksperimentalnim mamarnim karcinomon. Koriste}i isti model,
studirali smo u ovom radu patohistolo{ke karakteristike u tumoru i fenotipske promene u
subsetovima limfocita slezine. Za eksperimente smo koristili CBA/H mi{eve. Rast
eksperimentalnog tumora bio je indukovan injekcijom }elija mamarnog adenokarcinoma
intramuskularnom inokulacijom u femoralnu regiju mi{eva. @ivotinje su bile podelje na
kontrolnugrupuitrieksperimentalnepodgrupe(I,II,III).Mi{evieksperimentalnihgrupabilisu
tretiraniperoralnosa10mg/,100mg/i1000mgnakilogramtelesnemaseaskorbinskekiselineu
odnosunakontrolnugrupumi{evakojajeprimalafiziolo{kirastvor.Mi{evisu`rtvovani7.14.i
21. dana od po~etka eksperimenta. Odre|ivana je ukupna tumorska masa i njena patohistolo{ka
karakteristika, masa slezine i celularnost kao i relativni i ukupan broj T, B }elija i T }elijske
subpopulacije (CD4+ i CD8+) u slezini. Velike doze askorbinske kiseline smanjuju tumorsku
masu, stimuli{u proliferaciju fibroblasta i formiranje kapsule oko tumora, indukuju tumorsku
nekrozu kao i porast broja tumorom infiltriranih limfocita. Promene u subpopulaciji limfocita
kao i njihov broj varira zavisno od primenjene doze askorbinske kiseline i vremena trajanja
tumorske indukcije. Najzna~ajnije promene, manifestovane u porastu broja CD4+T }elija,
dobijene su 1‚4. dana u drugoj eksperimentalnoj grupi. Rezultati sugeri{u da je povoljan efekat
askorbinske kiseline na eksperimentalnu tumoro-genezu u na{em modelu posledica uticaja
tumora na imuni sistem. Acta Medica Medianae 2005;44(2): 23‡31.
Klju~ne re~i: mamarni adenokarcinom, mi{evi, askorbinska kiselina, histopatologija,
limfociti, fenotip